Reporting owner · Q3 2026 · CIK 2123975

Sahin Ugur: insider trades.

Sahin Ugur reported 19 non-derivative transactions on 10 SEC ownership filings in Q3 2026: 0 open-market purchases and 19 sales ($63.7M), across 1 company.

Transactions
19
Purchases (P)
0
Sales (S)
19
Companies
1
Name as filed
Sahin Ugur

Companies

CompanyRelationshipTransactions
BioNTech SE (BNTX)Officer, TenPercentOwner · Chief Executive Officer19

Transactions

19 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-30BioNTech SES32,000$98.12214,209Form 4
2026-09-29BioNTech SES34,000$98.26246,209Form 4
2026-09-28BioNTech SES34,000$98.47280,209Form 4
2026-09-25BioNTech SES27,000$98.69314,209Form 4
2026-09-24BioNTech SES39,000$98.99341,209Form 4
2026-09-23BioNTech SES30,000$99.4380,209Form 4
2026-09-22BioNTech SES46,000$100.72410,209Form 4
2026-09-21BioNTech SES33,000$97.81456,209Form 4
2026-09-18BioNTech SES30,000$96.22489,209Form 4
2026-09-17BioNTech SES34,000$98.6519,209Form 4
2026-09-16BioNTech SES15,000$96.09553,209Form 4
2026-09-15BioNTech SES34,000$96.49568,209Form 4
2026-09-14BioNTech SES41,000$99.45602,209Form 4
2026-09-11BioNTech SES45,000$96.93643,209Form 4
2026-09-10BioNTech SES20,500$96.31688,209Form 4
2026-09-09BioNTech SES36,000$97.78708,709Form 4
2026-09-08BioNTech SES37,000$99.2744,709Form 4
2026-09-04BioNTech SES31,500$103.52781,709Form 4
2026-09-03BioNTech SES45,000$102.85813,209Form 4

Questions

What stock did Sahin Ugur buy or sell?

Sahin Ugur reported 19 non-derivative transactions on 10 SEC ownership filings in Q3 2026: 0 open-market purchases and 19 sales ($63.7M), across 1 company.

Is Sahin Ugur the same person as other filers with this name?

This page covers SEC CIK 2123975 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/sahin-ugur-2123975.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.